Thomas Penzel

Prof. Thomas Penzel

Charité-Universitätsmedizin Berlin
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
ABAdam V Benjafield
Adam V Benjafield
NANajib T Ayas
Najib T Ayas
PEPeter R Eastwood
Peter R Eastwood
RHRaphael Heinzer
Raphael Heinzer
MIMary S M Ip
Mary S M Ip
AMAtul Malhotra
Atul Malhotra

18 February 2010 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
HVHenry Völzke
Henry Völzke
DADietrich Alte
Dietrich Alte
CSCarsten Oliver Schmidt
Carsten Oliver Schmidt
DRDörte Radke
Dörte Radke
RLRoberto Lorbeer
Roberto Lorbeer
WHWolfgang Hoffmann
Wolfgang Hoffmann
Although in the past century mortality in West Germany decreased similarly as in other Western nations, these changes were less pronounced in East Germany.1,2 After German reunification in 1990, there was a lack of scientifically valid data from East Germany to explain the regional differences in life expectancy and, consequently, a need for population-based research in northeast Germany.

7 January 2003 in Circulation
Verified
Journal Article
Closed access
HBHeinrich F. Becker
Heinrich F. Becker
AJAndreas Jerrentrup
Andreas Jerrentrup
TPThomas Ploch
Thomas Ploch
LGLudger Grote
Ludger Grote
Thomas PenzelThomas Penzel
Thomas Penzel
JPJ. Hermann Peter
J. Hermann Peter
Background— There is increasing evidence that obstructive sleep apnea (OSA) is an independent risk factor for arterial hypertension. Because there are no controlled studies showing a substantial effect of nasal continuous positive airway pressure (nCPAP) therapy on hypertension in OSA, the impact of treatment on cardiovascular sequelae has been questioned altogether. Therefore, we studied the effect of nCPAP on arterial hypertension in patients with OSA. Methods and Results— Sixty consecutive patients with moderate to severe OSA were randomly assigned to either effective or subtherapeutic nCPAP for 9 weeks on average. Nocturnal polysomnography and continuous noninvasive blood pressure recording for 19 hours was performed before and with treatment. Thirty two patients, 16 in each group, completed the study. Apneas and hypopneas were reduced by ≈95% and 50% in the therapeutic and subtherapeutic groups, respectively. Mean arterial blood pressure decreased by 9.9±11.4 mm Hg with effective nCPAP treatment, whereas no relevant change occurred with subtherapeutic nCPAP ( P =0.01). Mean, diastolic, and systolic blood pressures all decreased significantly by ≈10 mm Hg, both at night and during the day. Conclusions— Effective nCPAP treatment in patients with moderate to severe OSA leads to a substantial reduction in both day and night arterial blood pressure. The fact that a 50% reduction in the apnea-hypopnea index did not result in a decrease in blood pressure emphasizes the importance of highly effective treatment. The drop in mean blood pressure by 10 mm Hg would be predicted to reduce coronary heart disease event risk by 37% and stroke risk by 56%.

23 October 2000 in Physical Review Letters
Verified
Journal Article
Closed access
ABArmin Bunde
Armin Bunde
SHShlomo Havlin
Shlomo Havlin
JKJan W. Kantelhardt
Jan W. Kantelhardt
Thomas PenzelThomas Penzel
Thomas Penzel
JPJörg-Hermann Peter
Jörg-Hermann Peter
KVKarlheinz Voigt
Karlheinz Voigt
Healthy sleep consists of several stages: deep sleep, light sleep, and rapid eye movement (REM) sleep. Here we show that these sleep stages can be characterized and distinguished by correlations of heart rates separated by n beats. Using the detrended fluctuation analysis (DFA) up to fourth order we find that long-range correlations reminiscent to the wake phase are present only in the REM phase. In the non-REM phases, the heart rates are uncorrelated above the typical breathing cycle time, pointing to a random regulation of the heartbeat during non-REM sleep. DOI: http://dx.doi.org/10.1103/PhysRevLett.85.3736 © 2000 The American Physical Society

23 September 2003 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
Thomas PenzelThomas Penzel
Thomas Penzel
JKJ.W. Kantelhardt
J.W. Kantelhardt
LGL. Grote
L. Grote
JPJ.H. Peter
J.H. Peter
ABA. Bunde
A. Bunde
Sleep has been regarded as a testing situation for the autonomic nervous system, because its activity is modulated by sleep stages. Sleep-related breathing disorders also influence the autonomic nervous system and can cause heart rate changes known as cyclical variation. We investigated the effect of sleep stages and sleep apnea on autonomic activity by analyzing heart rate variability (HRV). Since spectral analysis is suited for the identification of cyclical variations and detrended fluctuation analysis can analyze the scaling behavior and detect long-range correlations, we compared the results of both complementary techniques in 14 healthy subjects, 33 patients with moderate, and 31 patients with severe sleep apnea. The spectral parameters VLF, LF, HF, and LF/HF confirmed increasing parasympathetic activity from wakefulness and REM over light sleep to deep sleep, which is reduced in patients with sleep apnea. Discriminance analysis was used on a person and sleep stage basis to determine the best method for the separation of sleep stages and sleep apnea severity. Using spectral parameters 69.7% of the apnea severity assignments and 54.6% of the sleep stage assignments were correct, while using scaling analysis these numbers increased to 74.4% and 85.0%, respectively. We conclude that changes in HRV are better quantified by scaling analysis than by spectral analysis.

1 October 2018 in Journal of Sleep Research
Verified
Journal Article
Closed access
PDF file
IFIngo Fietze
Ingo Fietze
NLNaima Laharnar
Naima Laharnar
AOAnne Obst
Anne Obst
RERalf Ewert
Ralf Ewert
SFStephan B. Felix
Stephan B. Felix
Thomas PenzelThomas Penzel
Thomas Penzel